Michael A. Riley - 26 Aug 2022 Form 4 Insider Report for Catalent, Inc.

Reporting relationship: Pres. Bio Product Delivery Div
Issuer ticker: N/A
Reported as of: 26 Aug 2022
Net transaction value: -$259,238
SEC form: 4
Accepted by SEC: 30 Aug 2022, 14:38:01 UTC
Prior SEC filing: 26 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Jose Ibietatorremendia, attorney-in-fact

Filing notes and source

Key filing fact

Michael A. Riley filed Form 4 for Catalent, Inc. on 30 Aug 2022.

Key facts

This page summarizes Michael A. Riley's Form 4 filing for Catalent, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 30 Aug 2022, 14:38.

Change

Previous filing in this sequence was filed on 26 Aug 2022.
Current net transaction value: -$259,238.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CTLT transaction

Common Stock

Sale

Transaction value: -$259,238
Shares: -2,491
Change %: -27%
Price: $104.07
Shares after: 6,592
Date: 26 Aug 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.

Footnote F2

Includes restricted stock units.